Reproductive rights supporters celebrated the U.S. Supreme Court's dismissal of a case challenging mifepristone, preserving medication abortion access but warning of potential future challenges by lower courts and state legislatures.
Legal expert Lawrence Gostin highlighted the ruling's limited scope, emphasizing that it didn't address the core issues of the case, leaving room for future restrictions on medication abortion and FDA's regulatory authority.
#supreme-court-ruling #medication-abortion-access #reproductive-rights #fda-regulation #legal-challenges
Collection
[
|
...
]